[{"_id":"551f89b731cae9239deb1f16","会社名":"東和薬品(株)【4553】","証券コード":"4553","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月14日","決算月数":"12か月","売上高":"61,351百万円","営業利益":"7,706百万円","経常利益":"8,834百万円","当期利益":"5,992百万円","EPS（一株当たり利益）":"352.61円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"3,539.07円","総資産":"103,318百万円","自己資本":"60,147百万円","資本金":"4,717百万円","有利子負債":"20,945百万円","自己資本比率":"58.2%","ROA（総資産利益率）":"6.21%","ROE（自己資本利益率）":"10.35%","総資産経常利益率":"9.15%","__v":0,"日付":"2015-04-04T06:50:31.206Z"},{"_id":"551f89b731cae9239deb1f17","会社名":"東和薬品(株)【4553】","証券コード":"4553","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月14日","決算月数":"12か月","売上高":"55,241百万円","営業利益":"7,723百万円","経常利益":"9,544百万円","当期利益":"6,201百万円","EPS（一株当たり利益）":"364.87円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"3,272.11円","総資産":"89,705百万円","自己資本":"55,610百万円","資本金":"4,717百万円","有利子負債":"16,133百万円","自己資本比率":"62.0%","ROA（総資産利益率）":"7.25%","ROE（自己資本利益率）":"11.69%","総資産経常利益率":"11.17%","__v":0,"日付":"2015-04-04T06:50:31.206Z"},{"_id":"551f89b731cae9239deb1f18","会社名":"東和薬品(株)【4553】","証券コード":"4553","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月14日","決算月数":"12か月","売上高":"48,719百万円","営業利益":"9,107百万円","経常利益":"9,841百万円","当期利益":"5,737百万円","EPS（一株当たり利益）":"334.48円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,971.07円","総資産":"81,244百万円","自己資本":"50,494百万円","資本金":"4,717百万円","有利子負債":"12,099百万円","自己資本比率":"62.2%","ROA（総資産利益率）":"7.44%","ROE（自己資本利益率）":"11.81%","総資産経常利益率":"12.76%","__v":0,"日付":"2015-04-04T06:50:31.207Z"}]